Aromyx, a Mountain View, Calif.-based company applying biotechnology and data science to capture sensory data, closed a $10M Series A round of financing.
The round was led by Rabo Food&Ag Innovation Fund and Sozo Ventures with participation from existing investors Ulu Ventures, Radicle Growth, Capital Energy and Merus Capital.
The funding will be used to help the company increase capacity and automation capabilities, generate more data, improve AI algorithms, and expand its lab and software teams.
Led by Josh Silverman, CEO, Aromyx uses the biological receptors from the human nose and tongue to create digital representations of sensory data for multiple applications. The technology allows customers to quantify, reproduce and understand human perception and provides direct testing services in addition to data analysis and software tools. By enabling clear, reproducible digital representations of smell and taste, the company’s tech has the potential to be applied across a wide range of industries and its products and services are in use at multiple Fortune 500 companies, in pharmaceuticals, chemicals, food & beverage and consumer packaged goods.
FinSMEs
21/07/2021